We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.21B +$55.7M +1,770,625 +5%
LSV Asset Management
27
LSV Asset Management
Illinois
$1.2B -$32.2M -1,024,630 -3%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$1.13B +$43.9M +1,396,529 +4%
TCIM
29
TIAA CREF Investment Management
New York
$1.08B +$19.3M +614,640 +2%
Fisher Asset Management
30
Fisher Asset Management
Washington
$1.04B +$13.5M +429,546 +1%
Capital International Investors
31
Capital International Investors
California
$952M +$241M +7,649,722 +33%
Wells Fargo
32
Wells Fargo
California
$939M +$34.3M +1,088,768 +4%
Boston Partners
33
Boston Partners
Massachusetts
$937M -$115M -3,656,468 -11%
Legal & General Group
34
Legal & General Group
United Kingdom
$933M +$1.95M +62,021 +0.2%
American Century Companies
35
American Century Companies
Missouri
$932M -$24.2M -769,958 -2%
Charles Schwab
36
Charles Schwab
California
$868M +$41.3M +1,314,235 +5%
BIM
37
BlackRock Investment Management
Delaware
$825M -$25.7M -815,745 -3%
PNC Financial Services Group
38
PNC Financial Services Group
Pennsylvania
$787M +$117M +3,713,108 +17%
Schroder Investment Management Group
39
Schroder Investment Management Group
United Kingdom
$786M -$41.3M -1,311,789 -5%
Nordea Investment Management
40
Nordea Investment Management
Sweden
$768M -$12.8M -408,081 -2%
Lazard Asset Management
41
Lazard Asset Management
New York
$755M +$3.94M +125,359 +0.5%
Allianz Asset Management
42
Allianz Asset Management
Germany
$695M +$151M +4,795,809 +27%
Neuberger Berman Group
43
Neuberger Berman Group
New York
$690M -$68M -2,161,103 -9%
CS
44
Credit Suisse
Switzerland
$672M +$155M +4,923,802 +29%
UBS AM
45
UBS AM
Illinois
$670M -$117M -3,721,647 -15%
LP
46
Longview Partners
Guernsey
$649M +$7.3M +232,179 +1%
Fidelity International
47
Fidelity International
Bermuda
$647M +$20.3M +645,067 +3%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$636M -$7.09M -225,258 -1%
Macquarie Group
49
Macquarie Group
Australia
$634M +$13.8M +438,335 +2%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$602M -$39M -1,239,006 -6%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.